Penumbra Inc (NYSE:PEN)
$ 186.94 -13.07 (-6.53%) Market Cap: 7.26 Bil Enterprise Value: 7.66 Bil PE Ratio: 549.82 PB Ratio: 6.25 GF Score: 82/100

Penumbra Inc at Canaccord Genuity Medical Technologies & Diagnostics Forum (Virtual) Transcript

Nov 19, 2020 / 06:30PM GMT
Release Date Price: $255.57 (-1.06%)
William John Plovanic
Canaccord Genuity Corp., Research Division - Analyst

Welcome. Thank you for participating in the Canaccord Genuity 14th Annual Medical Technologies and Diagnostics Forum. I'm Bill Plovanic, the senior medical device analyst here with Cannacord.

Our next fireside chat is with CEO of Penumbra, a medical device company focused on the development of innovative therapies to address challenging medical conditions with unmet needs. With me today is Adam Elsesser, CEO and Founder of Penumbra. Adam, thanks for joining me today.

Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO

Yes. Well, thanks for having me, Bill.

Questions & Answers

William John Plovanic
Canaccord Genuity Corp., Research Division - Analyst

I want to begin our discussion a little differently today and really go back to the genesis of Penumbra. I always find this interesting, having these questions and -- or having these discussions, and reminding us the why, the why behind the founding of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot